UniProt ID | SNX18_HUMAN | |
---|---|---|
UniProt AC | Q96RF0 | |
Protein Name | Sorting nexin-18 | |
Gene Name | SNX18 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 628 | |
Subcellular Localization |
Endomembrane system Peripheral membrane protein Cytoplasmic side. Endosome membrane Peripheral membrane protein Cytoplasmic side. Cell membrane Peripheral membrane protein Cytoplasmic side. Cytoplasmic vesicle membrane Peripheral membrane protein |
|
Protein Description | Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Stimulates the GTPase activity of DNM2. Promotes DNM2 location at the plasma membrane.. | |
Protein Sequence | MALRARALYDFRSENPGEISLREHEVLSLCSEQDIEGWLEGVNSRGDRGLFPASYVQVIRAPEPGPAGDGGPGAPARYANVPPGGFEPLPVAPPASFKPPPDAFQALLQPQQAPPPSTFQPPGAGFPYGGGALQPSPQQLYGGYQASQGSDDDWDDEWDDSSTVADEPGALGSGAYPDLDGSSSAGVGAAGRYRLSTRSDLSLGSRGGSVPPQHHPSGPKSSATVSRNLNRFSTFVKSGGEAFVLGEASGFVKDGDKLCVVLGPYGPEWQENPYPFQCTIDDPTKQTKFKGMKSYISYKLVPTHTQVPVHRRYKHFDWLYARLAEKFPVISVPHLPEKQATGRFEEDFISKRRKGLIWWMNHMASHPVLAQCDVFQHFLTCPSSTDEKAWKQGKRKAEKDEMVGANFFLTLSTPPAAALDLQEVESKIDGFKCFTKKMDDSALQLNHTANEFARKQVTGFKKEYQKVGQSFRGLSQAFELDQQAFSVGLNQAIAFTGDAYDAIGELFAEQPRQDLDPVMDLLALYQGHLANFPDIIHVQKGKAWPLEQVIWSVLCRLKGATLTAVPLWVSESYSTGEEASRDVDAWVFSLECKLDCSTGSFLLEYLALGNEYSFSKVQRVPLMTVLSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | SENPGEISLREHEVL CCCCCCCCCCCHHHH | 19.64 | 30266825 | |
54 | Phosphorylation | DRGLFPASYVQVIRA CCCCCCCHHEEEEEC | 26.52 | 21945579 | |
55 | Phosphorylation | RGLFPASYVQVIRAP CCCCCCHHEEEEECC | 9.30 | 21945579 | |
78 | Phosphorylation | GPGAPARYANVPPGG CCCCCCCCCCCCCCC | 12.48 | - | |
96 | Phosphorylation | LPVAPPASFKPPPDA CCCCCCCCCCCCCHH | 39.31 | 24719451 | |
173 | Phosphorylation | DEPGALGSGAYPDLD CCCCCCCCCCCCCCC | 22.54 | - | |
176 | Phosphorylation | GALGSGAYPDLDGSS CCCCCCCCCCCCCCC | 10.78 | - | |
193 | Phosphorylation | GVGAAGRYRLSTRSD CCCCCCCEEECCCCC | 18.26 | 28450419 | |
196 | Phosphorylation | AAGRYRLSTRSDLSL CCCCEEECCCCCCCC | 16.87 | 21722762 | |
197 | Phosphorylation | AGRYRLSTRSDLSLG CCCEEECCCCCCCCC | 38.49 | 28450419 | |
199 | Phosphorylation | RYRLSTRSDLSLGSR CEEECCCCCCCCCCC | 42.88 | 22617229 | |
202 | Phosphorylation | LSTRSDLSLGSRGGS ECCCCCCCCCCCCCC | 35.36 | 22617229 | |
205 | Phosphorylation | RSDLSLGSRGGSVPP CCCCCCCCCCCCCCC | 32.80 | 23403867 | |
206 | Methylation | SDLSLGSRGGSVPPQ CCCCCCCCCCCCCCC | 52.25 | 115917441 | |
209 | Phosphorylation | SLGSRGGSVPPQHHP CCCCCCCCCCCCCCC | 33.98 | 21722762 | |
233 | Phosphorylation | SRNLNRFSTFVKSGG HCCHHHHHHEEECCC | 20.07 | 29978859 | |
234 | Phosphorylation | RNLNRFSTFVKSGGE CCHHHHHHEEECCCE | 29.72 | 29978859 | |
253 | Ubiquitination | GEASGFVKDGDKLCV EECCEECCCCCEEEE | 54.45 | 21906983 | |
253 (in isoform 1) | Ubiquitination | - | 54.45 | 21906983 | |
253 (in isoform 2) | Ubiquitination | - | 54.45 | 21906983 | |
257 | Ubiquitination | GFVKDGDKLCVVLGP EECCCCCEEEEEECC | 49.68 | 22817900 | |
274 | Phosphorylation | PEWQENPYPFQCTID CCCCCCCCCEECEEC | 28.41 | 22817900 | |
294 | Phosphorylation | TKFKGMKSYISYKLV CCCCCCCCEEEEEEC | 20.85 | 26074081 | |
295 | Phosphorylation | KFKGMKSYISYKLVP CCCCCCCEEEEEECC | 6.59 | 26074081 | |
297 | Phosphorylation | KGMKSYISYKLVPTH CCCCCEEEEEECCCC | 14.16 | 26074081 | |
298 | Phosphorylation | GMKSYISYKLVPTHT CCCCEEEEEECCCCC | 9.97 | 26074081 | |
303 | Phosphorylation | ISYKLVPTHTQVPVH EEEEECCCCCCCCCC | 30.03 | 26074081 | |
305 | Phosphorylation | YKLVPTHTQVPVHRR EEECCCCCCCCCCHH | 33.47 | 26074081 | |
313 | Phosphorylation | QVPVHRRYKHFDWLY CCCCCHHHCCHHHHH | 14.58 | 26074081 | |
314 | Ubiquitination | VPVHRRYKHFDWLYA CCCCHHHCCHHHHHH | 35.66 | - | |
314 | Malonylation | VPVHRRYKHFDWLYA CCCCHHHCCHHHHHH | 35.66 | 26320211 | |
314 (in isoform 2) | Ubiquitination | - | 35.66 | - | |
326 | Ubiquitination | LYARLAEKFPVISVP HHHHHHHHCCCEECC | 49.73 | 22817900 | |
326 (in isoform 1) | Ubiquitination | - | 49.73 | 21906983 | |
326 (in isoform 2) | Ubiquitination | - | 49.73 | 21906983 | |
338 (in isoform 2) | Ubiquitination | - | 43.20 | 21906983 | |
338 | Malonylation | SVPHLPEKQATGRFE ECCCCCHHHCCCCCC | 43.20 | 26320211 | |
338 | Ubiquitination | SVPHLPEKQATGRFE ECCCCCHHHCCCCCC | 43.20 | 22817900 | |
338 (in isoform 1) | Ubiquitination | - | 43.20 | 21906983 | |
351 | Ubiquitination | FEEDFISKRRKGLIW CCHHHHHHHHHHHHH | 51.94 | 29967540 | |
432 | Ubiquitination | ESKIDGFKCFTKKMD HHHHCCEEEEEEECC | 33.69 | - | |
432 | Malonylation | ESKIDGFKCFTKKMD HHHHCCEEEEEEECC | 33.69 | 26320211 | |
432 (in isoform 2) | Ubiquitination | - | 33.69 | - | |
437 | Ubiquitination | GFKCFTKKMDDSALQ CEEEEEEECCCHHHH | 44.49 | 29967540 | |
437 | Malonylation | GFKCFTKKMDDSALQ CEEEEEEECCCHHHH | 44.49 | 26320211 | |
437 (in isoform 2) | Ubiquitination | - | 44.49 | - | |
438 | Sulfoxidation | FKCFTKKMDDSALQL EEEEEEECCCHHHHH | 8.04 | 30846556 | |
455 | Ubiquitination | TANEFARKQVTGFKK HHHHHHHHHHHCCHH | 45.77 | 29967540 | |
455 | Acetylation | TANEFARKQVTGFKK HHHHHHHHHHHCCHH | 45.77 | 19826923 | |
461 | Acetylation | RKQVTGFKKEYQKVG HHHHHCCHHHHHHHH | 46.14 | 19826933 | |
466 (in isoform 2) | Ubiquitination | - | 47.64 | - | |
466 | Acetylation | GFKKEYQKVGQSFRG CCHHHHHHHHHHHHC | 47.64 | 19826943 | |
466 | Ubiquitination | GFKKEYQKVGQSFRG CCHHHHHHHHHHHHC | 47.64 | 27667366 | |
544 (in isoform 2) | Phosphorylation | - | 11.07 | - | |
562 (in isoform 2) | Ubiquitination | - | 2.61 | 21906983 | |
611 (in isoform 2) | Phosphorylation | - | 40.53 | 27174698 | |
613 | Ubiquitination | LALGNEYSFSKVQRV HHHCCCCCCCCCCCC | 19.50 | 29967540 | |
613 (in isoform 2) | Ubiquitination | - | 19.50 | 21906983 | |
613 | Phosphorylation | LALGNEYSFSKVQRV HHHCCCCCCCCCCCC | 19.50 | 24719451 | |
620 | Ubiquitination | SFSKVQRVPLMTVLS CCCCCCCCCEEEEEC | 2.09 | 29967540 | |
623 (in isoform 2) | Phosphorylation | - | 1.67 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNX18_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX18_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX18_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ITCH_HUMAN | ITCH | physical | 20491914 | |
DYN2_HUMAN | DNM2 | physical | 26923255 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-193; SER-196; THR-197;SER-199 AND SER-202, AND MASS SPECTROMETRY. |